Federal Circuit Says Marketing Of Generic Fortesta Would Infringe

WASHINGTON, D.C. — A bench trial held by a Texas federal judge correctly ended in findings that patents covering the testosterone gel Fortesta are not invalid as anticipated or obvious, as...

Already a subscriber? Click here to view full article